Navigation Links
Multiple sclerosis drug serves as model for potential drugs to treat botulism poisoning
Date:11/17/2010

Scientists are reporting that variants of a drug already approved for treating multiple sclerosis show promise as a long sought treatment for victims of bioterrorist attack with botulinum neurotoxin which is 10,000 times deadlier than cyanide and the most poisonous substance known to man. The potential drugs also could be useful in treating other forms of botulism poisoning as well as Alzheimer's disease, multiple sclerosis, and myasthenia gravis, they say in an article in ACS Chemical Biology, a monthly journal.

Kim D. Janda and colleagues explain that the lack of any approved drug treatment for botulism poisoning leaves a major gap in defenses against bioterrorism and biological warfare. People exposed to botulism toxin develop paralysis, cannot breathe, and may require months of treatment on respirators. "The numbers of medical care units capable of providing supportive care for recovery in the event of a bioterrorism incident would be limited," they note.

The scientists knew that the multiple sclerosis drug diaminopyridine showed promise for working inside nerve cells to counteract the effects of diaminopyridine botulism toxin. However, diaminopyridine itself had disadvantages, including its ability to pass into the brain and have toxic effects on brain tissue. They modified the molecular structure of diaminopyridine to produce two new substances that did not enter the brain and showed good potential as botulism treatments in mice that had been paralyzed by the toxin.


'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

Page: 1

Related biology news :

1. To prevent inbreeding, flowering plants have evolved multiple genes, research reveals
2. Prostate cancers multiple personalities revealed
3. Study identifies key molecules in multiple myeloma
4. Risks in multiple pregnancies
5. The Joy of sets: For ants and trees, multiple partners are a boon
6. Ants found to use multiple antibiotics as weed killers
7. Brain atrophy responsible for depression in people battling multiple sclerosis
8. Virus infection may trigger unusual immune cells to attack nerves in multiple sclerosis
9. Cycad plant depends on insect for multiple services
10. Pistachios offer multiple benefits
11. Unexpectedly high rate of multiple strains in fungal infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... developed a novel technique that can detect molecular variants ... is one of the most important, though time-consuming, processes ... paper in Nature , post-doctoral researcher David Patterson, ... of the Center for Free-Electron Laser Science (CFEL) in ... microwave fields to identify molecular variants apart, and to ...
(Date:5/22/2013)... discovery of potential environmental and human health effects ... each year has led scientists to recommend stronger ... of lithium-ion (Li-ion) battery materials. That,s the conclusion ... Environmental Science & Technology . , Oladele ... batteries have become mainstays for powering everything from ...
(Date:5/22/2013)... for prostate cancer could become as easy for men ... UC Irvine research published today in the Journal ... than a decade of work, UC Irvine chemists have ... for prostate cancer in urine, meaning that the disease ... at dramatically lower cost. The same technology could potentially ...
Breaking Biology News(10 mins):Detecting mirror molecules 2Detecting mirror molecules 3UCI chemists devise inexpensive, accurate way to detect prostate cancer 2UCI chemists devise inexpensive, accurate way to detect prostate cancer 3
... When most people in the developed world think ... dim memory of a vaccination at a pediatrician,s office. ... North America and much of Europe, researchers remain interested ... because improving the measles vaccine could help eliminate the ...
... A simple technique to make a common virus-killing material ... labs of Andrew Barron and Qilin Li. Rather than ... put it into the public domain. They hope wide adoption ... The Rice professors and their team reported in Environmental ...
... Genetics Society of America (GSA) is pleased to announce ... 2011 at the Town & Country Resort & Conference ... together basic research scientists, who study genetic models in ... hereditary traits Thomas Hunt Morgan first studied nearly a ...
Cached Biology News:Measles virus, a weapon against cancer? 2Virus killer gets supercharged 2Virus killer gets supercharged 352nd Genetics Society of America Drosophila Research Conference announced 2
(Date:5/22/2013)... 22, 2013 AudioNotch ... for tinnitus treatment. AudioNotch is pleased to announce ... clinic locations in both British Columbia and Alberta, ... and hearing services. AudioNotch's tinnitus treatment program is ... entering a Destination Hearing clinic, patients have the ...
(Date:5/22/2013)... 22, 2013 Envera announced today that ... Mr. McErlean has an extensive background in cell ... throughout his career. , Mike Matheny, President ... to have Mike join our team”. “Mike’s background is ... fermentation and downstream processing equipment”, added Matheny. ...
(Date:5/21/2013)... May 22, 2013 First patients ... of glycopyrronium bromide designed using Prosonix, particle engineering platform ... a portfolio of inhaled Respiratory Medicines by Design ... PSX1002 that will assess its effect on lung function ... patients with moderate to severe chronic obstructive pulmonary disease ...
(Date:5/21/2013)... WA (PRWEB) May 21, 2013 Through ... trainings, and funds for lab equipment, 25 organizations will ... and importance of optics and photonics in daily life ... . , The organizations, located in 10 countries, are ... to be awarded by SPIE, the international society ...
Breaking Biology Technology:AudioNotch Tinnitus Treatment Launches Partnership With Destination Hearing 2Envera Appoints Michael McErlean Fermentation Manager 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 2Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 3
... China Medical,Technologies, Inc. (the "Company") (Nasdaq: ... develops, manufactures and markets advanced,in-vitro diagnostic products, today ... Bladder Cancer FISH Probe (the "Probe") from the ... People,s Republic of China. , ...
... providing the highest quality imaging. , ... Mill Creek, ... (a division of Westover Scientific, Inc.) announced today the launch of ... , , , ,The EVOS platform offers a fully integrated digital ...
... Conn. As researchers push towards detection of single ... mass and movement, Yale researchers have demonstrated silicon-based nanocantilevers, ... photonic principles eliminating the need for electric transducers and ... April 26 advance online publication of Nature Nanotechnology ...
Cached Biology Technology:AMG Launches EVOS fl, an 'Evolutionary' Fluorescence Microscope Based on Innovative EVOS Platform 2Catching the lightwave: Nano-mechanical sensors 'wired' by photonics 2